System Status: EU Exit: Is your UK regulatory status or UK availability timeline affected? Add any relevant information to the ‘Information on EMA/MHRA decisions’ free text box (below the ‘Actual UK availability date’ field).

UK Pharmascan logo
An essential first step to market access for medicines

Home - UK Pharmascan

What is UK PharmaScan?

UK PharmaScan is a database of information on new medicines, indications, and formulations in the pharmaceutical pipeline. It is the primary source of information used by all of the UK’s national horizon scanning organisations and NHS England to enable early engagement in planning and preparing the NHS for the introduction of new medicines, and to support faster NHS adoption. It is populated by companies on a confidential and secure platform.

Early engagement and NHS planning have been shown to improve the speed of medicines uptake. By regularly entering comprehensive information on pipeline medicines into UK PharmaScan, product developers ensure the NHS horizon scanning organisations have the information they need.

Read more about:
Market access routes in England (PDF opens in new window or tab)
Market access routes in Scotland and Wales (PDF opens in new window or tab)

There is no charge for pharmaceutical companies to use UK PharmaScan.

Confidential and secure database

Data entered in UK PharmaScan are only accessible to the manafacturer, NHS England and horizon scanning organisations. Robust web security safeguards are in place and all organisations are covered by the confidentiality clauses in their signed User Agreements.

Why should pharmaceutical companies use UK PharmaScan?

Effective

The easiest way to communicate with UK horizon scanning organisations.

Market access

An essential first step to market access for medicines in England, Scotland, Wales and Northern Ireland.

Read our information leaflet on UK PharmaScan

View our overview presentation (PowerPoint)

Efficient

Companies make one common submission to multiple organisations.